Literature DB >> 10376747

A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy.

A de Graeff1, R J de Leeuw, W J Ros, G J Hordijk, J J Battermann, G H Blijham, J A Winnubst.   

Abstract

BACKGROUND: The aim of this study was to describe prospectively quality of life and mood before and after radiotherapy for laryngeal cancer.
METHODS: Sixty-five patients with Tis-T3 laryngeal cancer treated with radiotherapy completed the European Organization for Research and Treatment of Cancer (EORTC) Core Questionnaire, the EORTC Head and Neck Cancer module, and the Center for Epidemiologic Studies Depression Scale before treatment and 6 and 12 months later.
RESULTS: There was a significant but temporary deterioration of physical functioning, fatigue and most head and neck symptoms. Speech was the only symptom which improved. Patients with T2 tumors had significantly worse physical symptoms compared with patients with T1 tumors. There was a high level of depressive symptomatology at baseline, followed by an improvement after treatment.
CONCLUSIONS: After radiotherapy for laryngeal cancer, a temporary deterioration of physical functioning and symptoms occurs, mostly caused by side effects of treatment. Despite physical deterioration, there is an improvement of emotional functioning and mood after treatment, probably as a result of psychological adaptation and coping processes.

Entities:  

Mesh:

Year:  1999        PMID: 10376747     DOI: 10.1002/(sici)1097-0347(199907)21:4<291::aid-hed1>3.0.co;2-b

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  24 in total

1.  Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment.

Authors:  C L Lazarus; H Husaini; K Hu; B Culliney; Z Li; M Urken; A Jacobson; M Persky; T Tran; C Concert; D Palacios; R Metcalfe-Klaw; M Kumar; B Bennett; L Harrison
Journal:  Dysphagia       Date:  2014-03-08       Impact factor: 3.438

2.  A survey of variables used by speech-language pathologists to assess function and predict functional recovery in oral cancer patients.

Authors:  Hasan Husaini; Gintas P Krisciunas; Susan Langmore; Jacqueline K Mojica; Mark L Urken; Adam S Jacobson; Cathy L Lazarus
Journal:  Dysphagia       Date:  2014-03-08       Impact factor: 3.438

3.  Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms.

Authors:  Julia R Van Liew; Rebecca L Brock; Alan J Christensen; Lucy Hynds Karnell; Nitin A Pagedar; Gerry F Funk
Journal:  Head Neck       Date:  2016-10-05       Impact factor: 3.147

4.  One-year effect of a nurse-led psychosocial intervention on depressive symptoms in patients with head and neck cancer: a randomized controlled trial.

Authors:  Ingeborg C van der Meulen; Anne M May; Wynand J G Ros; Miriam Oosterom; Gert-Jan Hordijk; Ron Koole; J Rob J de Leeuw
Journal:  Oncologist       Date:  2013-02-21

5.  Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).

Authors:  C M L van Herpen; M E Mauer; R Mesia; M Degardin; S Jelic; C Coens; J Betka; J Bernier; E Remenar; J S Stewart; J H Preiss; D van den Weyngaert; A Bottomley; J B Vermorken
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

Review 6.  Quality-of-life outcomes in head and neck cancer patients.

Authors:  Randall P Morton; Mark E Izzard
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

Review 7.  Next-Gen Therapeutics for Skin Cancer: Nutraceuticals.

Authors:  Annapoorna Sreedhar; Jun Li; Yunfeng Zhao
Journal:  Nutr Cancer       Date:  2018-05-15       Impact factor: 2.900

8.  Swallowing function outcomes following nonsurgical therapy for advanced-stage laryngeal carcinoma.

Authors:  James Paul Dworkin; Samuel L Hill; Robert J Stachler; Robert J Meleca; Danny Kewson
Journal:  Dysphagia       Date:  2006-01       Impact factor: 3.438

9.  Cancer: disease and nutrition are key determinants of patients' quality of life.

Authors:  Paula Ravasco; Isabel Monteiro-Grillo; Pedro Marques Vidal; Maria E Camilo
Journal:  Support Care Cancer       Date:  2004-03-03       Impact factor: 3.603

10.  A randomized clinical trial to evaluate the impact of a dental care program in the quality of life of head and neck cancer patients.

Authors:  Camila Samara Funk; Cristine Maria Warmling; Julio Baldisserotto
Journal:  Clin Oral Investig       Date:  2013-08-30       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.